This finding offers a new research avenue for the treatment of AD by inhibiting the expression of DLAT through blocking the transfer of PKM2 by microglia‐derived extracellular vesicles, potentially attenuating neuronal copper‐mediated death and slowing down AD progression [68]. This evidence concerns the gene PKM and Alzheimer disease.